Alnylam Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (41)

View All

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
Article By: Zacks Investment Research
Saturday, March 9, 2024 1:40 PM EDT
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung cancer medicine, Rybrevant, for first-line use.
In this article: AZN, JNJ, NVO, RHHBY, ALNY Also: MRK, PFE
Read
3 Lesser-Known Biotech Stocks That Are Surging
Article By: StockNews
Thursday, January 21, 2021 7:40 AM EDT
Biotechnology was one of the most popular sectors in 2020. The coronavirus pandemic drew attention to the sector due to the urgent need for COVID-19 testing supplies and a vaccine.
In this article: ALNY, BGNE, ZLAB
Read
Alnylam Launches “Alnylam P5x25” Strategy For Planned Transition To A Top Five Biotech In Market Capitalization Over Next Five Years
Article By: Business Wire
Sunday, January 10, 2021 3:08 PM EDT
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced its new five-year strategy, “Alnylam P5x25,” which is focused on the company’s transition to a top-5 biotech (measured by market capitalization) in the next five years.
In this article: ALNY
Read
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
Article By: Benzinga
Sunday, April 12, 2020 1:22 PM EDT
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.
In this article: ABT, JNJ, ALNY, GILD, ISRG, AMRN, AXSM, SCYX, ASND, URGN, ITRM, OVID, VIR
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
All Posts

Latest Tweets for $ALNY

No tweets yet!

PARTNER HEADLINES